BUZZ-Cardinal Health rises on upbeat 2025 profit

Shares of drug distributor Cardinal Health CAH.N rise 3.5% to $132.20

CAH expects FY 2025 adj. EPS of $7.85 to $8.00, up from previous range of $7.75 to $7.90, as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit

CAH reports Q2 EPS of $1.93, above analysts' est. of $1.76 - LSEG

CAH posts Q2 rev. of $55.26 bln vs. analysts' est. of $55.02 bln - LSEG

CAH gained 17.3% in 2024